Healthequity, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
HealthEquity, Inc. announced robust financial and operational results for fiscal year 2026, including significant increases in revenue, net income, and HSA assets, alongside proposals for new employee equity incentive plans.
NASDAQ
HealthEquity, Inc. is holding its annual stockholder meeting on June 26, 2025, and has released its proxy materials.
NASDAQ
HealthEquity, Inc. is set to hold its 2025 annual meeting on June 26, 2025, featuring proposals for director elections, auditor ratification, and executive compensation approval.
NASDAQ
HealthEquity, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
HealthEquity is asking stockholders to approve the 2024 Equity Incentive Plan to continue incentivizing employees and align their interests with those of shareholders.